SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,

Page 1 <img data-url='document/sabcs-2018-oncoletter-committee-member-for-the-impassion130-and-kate2-trials-this.html?page=1' data-page='1' class='cut-thumb lazyload' alt='Page 1: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader035.cupdf.com/reader035/viewer/2022070719/5edef41cad6a402d666a509c/html5/thumbnails/1.jpg' width='140' height='200' /> SABCS 2018

Page 2 <img data-url='document/sabcs-2018-oncoletter-committee-member-for-the-impassion130-and-kate2-trials-this.html?page=2' data-page='2' class='cut-thumb lazyload' alt='Page 2: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader035.cupdf.com/reader035/viewer/2022070719/5edef41cad6a402d666a509c/html5/thumbnails/2.jpg' width='140' height='200' /> SABCS 2018

Page 3 <img data-url='document/sabcs-2018-oncoletter-committee-member-for-the-impassion130-and-kate2-trials-this.html?page=3' data-page='3' class='cut-thumb lazyload' alt='Page 3: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader035.cupdf.com/reader035/viewer/2022070719/5edef41cad6a402d666a509c/html5/thumbnails/3.jpg' width='140' height='200' /> SABCS 2018

Page 4 <img data-url='document/sabcs-2018-oncoletter-committee-member-for-the-impassion130-and-kate2-trials-this.html?page=4' data-page='4' class='cut-thumb lazyload' alt='Page 4: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader035.cupdf.com/reader035/viewer/2022070719/5edef41cad6a402d666a509c/html5/thumbnails/4.jpg' width='140' height='200' /> SABCS 2018

Page 5 <img data-url='document/sabcs-2018-oncoletter-committee-member-for-the-impassion130-and-kate2-trials-this.html?page=5' data-page='5' class='cut-thumb lazyload' alt='Page 5: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader035.cupdf.com/reader035/viewer/2022070719/5edef41cad6a402d666a509c/html5/thumbnails/5.jpg' width='140' height='200' /> SABCS 2018

Page 6 <img data-url='document/sabcs-2018-oncoletter-committee-member-for-the-impassion130-and-kate2-trials-this.html?page=6' data-page='6' class='cut-thumb lazyload' alt='Page 6: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader035.cupdf.com/reader035/viewer/2022070719/5edef41cad6a402d666a509c/html5/thumbnails/6.jpg' width='140' height='200' /> SABCS 2018

Page 7 <img data-url='document/sabcs-2018-oncoletter-committee-member-for-the-impassion130-and-kate2-trials-this.html?page=7' data-page='7' class='cut-thumb lazyload' alt='Page 7: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader035.cupdf.com/reader035/viewer/2022070719/5edef41cad6a402d666a509c/html5/thumbnails/7.jpg' width='140' height='200' /> SABCS 2018

Page 8 <img data-url='document/sabcs-2018-oncoletter-committee-member-for-the-impassion130-and-kate2-trials-this.html?page=8' data-page='8' class='cut-thumb lazyload' alt='Page 8: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader035.cupdf.com/reader035/viewer/2022070719/5edef41cad6a402d666a509c/html5/thumbnails/8.jpg' width='140' height='200' /> SABCS 2018

Page 9 <img data-url='document/sabcs-2018-oncoletter-committee-member-for-the-impassion130-and-kate2-trials-this.html?page=9' data-page='9' class='cut-thumb lazyload' alt='Page 9: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader035.cupdf.com/reader035/viewer/2022070719/5edef41cad6a402d666a509c/html5/thumbnails/9.jpg' width='140' height='200' /> SABCS 2018

Page 10 <img data-url='document/sabcs-2018-oncoletter-committee-member-for-the-impassion130-and-kate2-trials-this.html?page=10' data-page='10' class='cut-thumb lazyload' alt='Page 10: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader035.cupdf.com/reader035/viewer/2022070719/5edef41cad6a402d666a509c/html5/thumbnails/10.jpg' width='140' height='200' /> SABCS 2018

SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F. Hoffmann-La Roche, Ltd Editorial support, funded by the sponsor,

Documents